Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Sernova Corp T.SVA

Alternate Symbol(s):  SEOVF

Sernova Corp. is a Canada-based clinical-stage biotechnology company, which is developing therapeutic cell technologies for chronic diseases, including insulin-dependent diabetes, thyroid disease, and blood disorders that include hemophilia A. The Company is focused on developing a functional cure for insulin-dependent diabetes with its therapeutic cell technology, the Cell Pouch System, a novel implantable and scalable medical device with immune protected therapeutic cells. The Cell Pouch is a scalable, implantable medical device. The Cell Pouch is designed to create a vascularized organ-like environment for the transplantation and engraftment of therapeutic cells. Its regenerative medicine therapeutic approach is to provide cell therapies where the cells, transplanted within an organ-like vascularized implantable device, the Cell Pouch, generates proteins, hormones or factors released into the bloodstream for treatment of diseases requiring replacement of these molecules in the body.


TSX:SVA - Post by User

Comment by Redbaron2211on Jun 15, 2022 1:10am
179 Views
Post# 34757106

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:Used BioTech Company For Sale by Owner - 600M OBO.

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:Used BioTech Company For Sale by Owner - 600M OBO. The writing was on the wall but at least they were able to get to this point during the last couple years.  The cash in the bank came just in time and at a reasonable price that underpins the valuation and not having to raise money in a potential recession is a big derisk.  

I'm not sure Sernova will have to do much for marketing to be on the radar of institutions and attract investment now that they are in bed with Evotec.   The problem now is the lack of institutional money flow into the sector and the markets in general for that matter.  When that changes and inflows pick up Sernova should catch some bids and start to turn over its retail base. 

   


BioTeck wrote: Yes we did see this all coming. Everyone except the company. All this institution talk only makes sense if in fact institutions are aware of our existence. I question Sernovas ability to market. They have done a horrible job with retail so I don't see them doing a superb job with institutions. The proof is in the pudding and I don't see institutions or anyone pudding in any bids.
Redbaron2211 wrote: Agree MS especially with all the macro uncertainties.  The way management can protect the company from a cheap takeover would be a push for more institutional buying.  Unfortunately it doesn't come easy in this environment.  With the current sentiment and breadth extremes we are due for a multi month rebound in markets and given what DF points out with Sernova looking attractive at these valuations I agree and feel this will promote institutions to start accumulating when they are given the green light to do so.  




<< Previous
Bullboard Posts
Next >>